Leadership & Pay ·
Azenta, Inc. appointed Dr. Martin D. Madaus as Interim President and CEO effective August 22, 2026, with the Board…
AZTAAzenta, Inc.
Azenta, Inc. appointed Dr. Martin D. Madaus as Interim President and CEO effective August 22, 2026, with the Board approving a compensation package on September 14, 2026. The agreement includes a $600,000 annual base salary and a cash performance bonus equal to 100% of base salary, payable January 1, 2028, contingent on continued employment. Madaus also received restricted stock units valued at $1,200,000, vesting monthly over one year. Additionally, the Board approved one-time retention awards for four named executive officers: Lawrence Lin ($1,000,000), Ephraim Starr ($500,000), Olga Pirogova ($500,000), and Trey Martin ($500,000). These awards consist of time-based restricted stock units vesting 50% on the first and second anniversaries of the grant date. The Board also reconstituted its Nominating and Governance Committee. Azenta operates in the life sciences technology sector, providing instruments, consumables, and services for sample management and analysis.